1.7M
XNAS Volume
High vol.+loss this week
XNAS 19 Mar, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Sutro Biopharma Inc is on 25 Mar 2025 for the purpose of Sutro Biopharma Inc Fourth Quarter Earnings Results for 2024
See details
Low Financial Strength
Expensive Valuation
Technically Bearish
Weak Stock
These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks.
View Similar
Embed DVM
Sutro Biopharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..